Janux Therapeutics, Inc.

8.99 USD
-0.05 (-0.55%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Janux Therapeutics, Inc. stock is up 32.79% since 30 days ago. The next earnings date is Mar 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 2 December’s closed higher than November. 100% of analysts rate it a buy.

About Janux Therapeutics, Inc.

Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology. The company was incorporated in 2017 and is headquartered in La Jolla, California.

  • HC Wainwright & Co.
    Mon Nov 13, 10:43
  • Wedbush
    Wed Nov 8, 08:54